Search Results - Fadime Dogan
- Showing 1 - 5 results of 5
-
1
The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation by Amber Blaauboer, Peter M. van Koetsveld, Dana A. M. Mustafa, Jasper Dumas, Fadime Dogan, Suzanne van Zwienen, Casper H. J. van Eijck, Leo J. Hofland
Published in Biomedicines (2022-02-01)Get full text
Article -
2
Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients by Julie Refardt, Maria J. Klomp, Peter M. vanKoetsveld, Fadime Dogan, Mark Konijnenberg, Tessa Brabander, Richard A. Feelders, Wouter W. deHerder, Leo J. Hofland, Johannes Hofland
Published in Clinical and Translational Medicine (2022-07-01)Get full text
Article -
3
The Role of the <i>IGF2</i> Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue by Rebecca V. Steenaard, Richard A. Feelders, Fadime Dogan, Peter M. van Koetsveld, Sara G. Creemers, Madeleine H. T. Ettaieb, Folkert J. van Kemenade, Harm R. Haak, Leo J. Hofland
Published in Biomedicines (2023-07-01)Get full text
Article -
4
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo by Maria J. Klomp, Leo J. Hofland, Lilian van den Brink, Peter M. van Koetsveld, Fadime Dogan, Corrina M. A. de Ridder, Debra C. Stuurman, Marian C. Clahsen-van Groningen, Marion de Jong, Simone U. Dalm
Published in Pharmaceutics (2022-01-01)Get full text
Article -
5
Epigenetic regulation of SST2 expression in small intestinal neuroendocrine tumors by Maria J. Klomp, Maria J. Klomp, Julie Refardt, Julie Refardt, Peter M. van Koetsveld, Claudia Campana, Claudia Campana, Simone U. Dalm, Fadime Dogan, Marie-Louise F. van Velthuysen, Richard A. Feelders, Wouter W. de Herder, Johannes Hofland, Leo J. Hofland
Published in Frontiers in Endocrinology (2023-05-01)Get full text
Article
